Emergent Devices, Inc.
UnclaimedPharmaceutical Preparation ManufacturingPlymouth Meeting, PA
Founded
2013
Primary NAICS
325412
CAGE code
7ARJ9
Federal awards
$6.1M
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of State | $284,784 | 3 |
| 2026 | Department of Veterans Affairs | $0 | 2 |
| 2025 | Department of Homeland Security | $111,802 | 2 |
| 2025 | Department of Veterans Affairs | $0 | 4 |
| 2025 | Department of Health and Human Services | -$139 | 1 |
| 2025 | Department of Justice | -$1,696 | 1 |
| 2024 | Department of Homeland Security | $341,262 | 6 |
| 2024 | Department of Justice | $1,356 | 4 |
| 2024 | Department of Veterans Affairs | $0 | 5 |
| 2024 | Department of Defense | -$4,583 | 1 |
| 2023 | Department of Veterans Affairs | $542,736 | 9 |
| 2023 | Department of Homeland Security | $19,386 | 4 |
| 2023 | Department of Defense | $4,523 | 4 |
| 2022 | Department of Veterans Affairs | $3,325,920 | 15 |
| 2022 | Department of Health and Human Services | $780,528 | 1 |
| 2022 | Department of Homeland Security | $420,128 | 5 |
| 2022 | Department of State | $141,683 | 1 |
| 2022 | Department of Defense | $51,028 | 11 |
| 2022 | Department of Justice | $34,245 | 7 |